Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient.
Navarro
José-Tomás
JT
Ribera
Josep-Maria
JM
Juncà
Jordi
J
Millá
Fuensanta
F
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000473:pathology* / Q000821:virology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001005:Anus Neoplasms / Q000150:complications / Q000188:drug therapy / Q000473:pathology* / Q000821:virology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D020031:Epstein-Barr Virus Infections / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D017809:Fatal Outcome; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D019288:Herpesvirus 8, Human / Q000302:isolation & purification*; D006716:Homosexuality; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000150:complications / Q000188:drug therapy / Q000473:pathology* / Q000821:virology; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone